[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

GB201702603D0 - Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders - Google Patents

Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Info

Publication number
GB201702603D0
GB201702603D0 GBGB1702603.0A GB201702603A GB201702603D0 GB 201702603 D0 GB201702603 D0 GB 201702603D0 GB 201702603 A GB201702603 A GB 201702603A GB 201702603 D0 GB201702603 D0 GB 201702603D0
Authority
GB
United Kingdom
Prior art keywords
compositions
treatment
inflammatory disorders
pharmaceutical compositions
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1702603.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galapagos NV
Original Assignee
Galapagos NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galapagos NV filed Critical Galapagos NV
Priority to GBGB1702603.0A priority Critical patent/GB201702603D0/en
Publication of GB201702603D0 publication Critical patent/GB201702603D0/en
Priority to EP18707866.2A priority patent/EP3582775A1/en
Priority to CA3054652A priority patent/CA3054652A1/en
Priority to MX2019009658A priority patent/MX2019009658A/en
Priority to BR112019016949-0A priority patent/BR112019016949A2/en
Priority to AU2018221761A priority patent/AU2018221761A1/en
Priority to SG11201907492TA priority patent/SG11201907492TA/en
Priority to MA047495A priority patent/MA47495A/en
Priority to JP2019544638A priority patent/JP2020507612A/en
Priority to KR1020197027092A priority patent/KR20190117672A/en
Priority to CN201880012183.5A priority patent/CN110300586A/en
Priority to PCT/EP2018/053803 priority patent/WO2018149925A1/en
Priority to PH12019501853A priority patent/PH12019501853A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB1702603.0A 2017-02-17 2017-02-17 Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders Ceased GB201702603D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GBGB1702603.0A GB201702603D0 (en) 2017-02-17 2017-02-17 Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders
PCT/EP2018/053803 WO2018149925A1 (en) 2017-02-17 2018-02-15 Anti-inflammatory compositions comprising irak and jak inhibitors
SG11201907492TA SG11201907492TA (en) 2017-02-17 2018-02-15 Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders
CA3054652A CA3054652A1 (en) 2017-02-17 2018-02-15 Anti-inflammatory compositions comprising irak and jak inhibitors
MX2019009658A MX2019009658A (en) 2017-02-17 2018-02-15 Anti-inflammatory compositions comprising irak and jak inhibitors.
BR112019016949-0A BR112019016949A2 (en) 2017-02-17 2018-02-15 ANTI-INFLAMMATORY COMPOSITIONS THAT UNDERSTAND IRAK AND JAK INHIBITORS
AU2018221761A AU2018221761A1 (en) 2017-02-17 2018-02-15 Anti-inflammatory compositions comprising IRAK and JAK inhibitors
EP18707866.2A EP3582775A1 (en) 2017-02-17 2018-02-15 Anti-inflammatory compositions comprising irak and jak inhibitors
MA047495A MA47495A (en) 2017-02-17 2018-02-15 ANTI-INFLAMMATORY COMPOSITIONS INCLUDING IRAQ AND JAK INHIBITORS
JP2019544638A JP2020507612A (en) 2017-02-17 2018-02-15 Anti-inflammatory composition comprising IRAK inhibitor and JAK inhibitor
KR1020197027092A KR20190117672A (en) 2017-02-17 2018-02-15 Anti-Inflammatory Compositions Including IRR and JAP Inhibitors
CN201880012183.5A CN110300586A (en) 2017-02-17 2018-02-15 Anti-inflammatory composition comprising IRAK and JAK inhibitor
PH12019501853A PH12019501853A1 (en) 2017-02-17 2019-08-08 Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1702603.0A GB201702603D0 (en) 2017-02-17 2017-02-17 Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Publications (1)

Publication Number Publication Date
GB201702603D0 true GB201702603D0 (en) 2017-04-05

Family

ID=58486866

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1702603.0A Ceased GB201702603D0 (en) 2017-02-17 2017-02-17 Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders

Country Status (13)

Country Link
EP (1) EP3582775A1 (en)
JP (1) JP2020507612A (en)
KR (1) KR20190117672A (en)
CN (1) CN110300586A (en)
AU (1) AU2018221761A1 (en)
BR (1) BR112019016949A2 (en)
CA (1) CA3054652A1 (en)
GB (1) GB201702603D0 (en)
MA (1) MA47495A (en)
MX (1) MX2019009658A (en)
PH (1) PH12019501853A1 (en)
SG (1) SG11201907492TA (en)
WO (1) WO2018149925A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019111218A1 (en) 2017-12-08 2019-06-13 Cadila Healthcare Limited Novel heterocyclic compounds as irak4 inhibitors
CN113713083A (en) * 2020-05-25 2021-11-30 南京帝昌医药科技有限公司 Pharmaceutical composition for treating alopecia
WO2022028556A1 (en) 2020-08-07 2022-02-10 南京药石科技股份有限公司 Cdk9 inhibitor and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3041B1 (en) 2008-07-25 2016-09-05 Galapagos Nv Novel compounds useful for the treatment of degenerative and inflammatory diseases
TWI462920B (en) 2009-06-26 2014-12-01 葛萊伯格有限公司 Novel compound useful for the treatment of degenerative and inflammatory diseases
AU2013279597B2 (en) 2012-06-22 2017-04-20 Alfasigma S.P.A. Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof
GB201402071D0 (en) 2014-02-07 2014-03-26 Galapagos Nv Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201402070D0 (en) 2014-02-07 2014-03-26 Galapagos Nv Pharmaceutical compositions for the treatment of inflammatory disorders
GB201518456D0 (en) * 2015-10-19 2015-12-02 Galapagos Nv Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory, autoimmune and/or proliferative diseases
US20170173034A1 (en) * 2015-12-17 2017-06-22 Gilead Sciences, Inc. Combination of a jak inhibitor and a syk inhibitor for treating cancers and inflammatory disorders

Also Published As

Publication number Publication date
KR20190117672A (en) 2019-10-16
PH12019501853A1 (en) 2020-06-15
AU2018221761A1 (en) 2019-10-03
CN110300586A (en) 2019-10-01
MA47495A (en) 2019-12-25
SG11201907492TA (en) 2019-09-27
JP2020507612A (en) 2020-03-12
CA3054652A1 (en) 2018-08-23
WO2018149925A1 (en) 2018-08-23
EP3582775A1 (en) 2019-12-25
BR112019016949A2 (en) 2020-05-26
MX2019009658A (en) 2019-10-02

Similar Documents

Publication Publication Date Title
ZA202004025B (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
ZA202002166B (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
IL255109A0 (en) Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
IL246833A0 (en) Novel salts and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201411241D0 (en) Novel dihydropyridoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders
HRP20181332T1 (en) Benzimidazole derivatives and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201610056D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis
IL286688A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
IL286677A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201911868D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201610055D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders and osteoarthritis
GB201702603D0 (en) Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders
IL286685A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201702604D0 (en) Novel compositions and pharmaceutical compositions thereof for the treatment of inflammatory disorders
GB201807222D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of inflammation disorders
GB201720101D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
GB201718856D0 (en) Medicinal compositions for the treatment of inflammatory conditions and autoimmune diseases

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)